[Status of TTT in the therapy for CNV]

Standard

[Status of TTT in the therapy for CNV]. / Feucht, M; Fuisting, Bettina; Richard, G.

in: KLIN MONATSBL AUGENH, Jahrgang 223, Nr. 10, 10, 2006, S. 802-807.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Feucht M, Fuisting B, Richard G. [Status of TTT in the therapy for CNV]. KLIN MONATSBL AUGENH. 2006;223(10):802-807. 10.

Bibtex

@article{9f063a9a5cb64cc7965b2356d5239274,
title = "[Status of TTT in the therapy for CNV]",
abstract = "Transpupillary thermotherapy (TTT) and photodynamic therapy (PDT) are recent treatment options for choroidal neovascularisation (CNV). In PDT a photochemical reaction is induced by the injection of a photosensitising substance. In contrast to this, TTT is a non-invasive photothermal treatment option for CNV and choroidal tumours. It leads to a low-grade-hyperthermia with consecutive induction of metabolic processes and production of heat-shock proteins in order to restore cellular homeostasis. Classical laser coagulation as recommended by the Macular Photocoagulation Study Group produces a photocoagulative effect with significant tissue hyperthermia and prompt visual loss. For classic CNV, PDT represents an established therapy option. Positive results of the treatment of occult CNV by PDT have enlarged the use of PDT to this kind of CNV. TTT represents an economic therapy modality for (mainly) occult CNV. The effect for visual outcome varies in different studies. The results are shown in a .",
author = "M Feucht and Bettina Fuisting and G Richard",
year = "2006",
language = "Deutsch",
volume = "223",
pages = "802--807",
journal = "KLIN MONATSBL AUGENH",
issn = "0023-2165",
publisher = "Ferdinand Enke Verlag",
number = "10",

}

RIS

TY - JOUR

T1 - [Status of TTT in the therapy for CNV]

AU - Feucht, M

AU - Fuisting, Bettina

AU - Richard, G

PY - 2006

Y1 - 2006

N2 - Transpupillary thermotherapy (TTT) and photodynamic therapy (PDT) are recent treatment options for choroidal neovascularisation (CNV). In PDT a photochemical reaction is induced by the injection of a photosensitising substance. In contrast to this, TTT is a non-invasive photothermal treatment option for CNV and choroidal tumours. It leads to a low-grade-hyperthermia with consecutive induction of metabolic processes and production of heat-shock proteins in order to restore cellular homeostasis. Classical laser coagulation as recommended by the Macular Photocoagulation Study Group produces a photocoagulative effect with significant tissue hyperthermia and prompt visual loss. For classic CNV, PDT represents an established therapy option. Positive results of the treatment of occult CNV by PDT have enlarged the use of PDT to this kind of CNV. TTT represents an economic therapy modality for (mainly) occult CNV. The effect for visual outcome varies in different studies. The results are shown in a .

AB - Transpupillary thermotherapy (TTT) and photodynamic therapy (PDT) are recent treatment options for choroidal neovascularisation (CNV). In PDT a photochemical reaction is induced by the injection of a photosensitising substance. In contrast to this, TTT is a non-invasive photothermal treatment option for CNV and choroidal tumours. It leads to a low-grade-hyperthermia with consecutive induction of metabolic processes and production of heat-shock proteins in order to restore cellular homeostasis. Classical laser coagulation as recommended by the Macular Photocoagulation Study Group produces a photocoagulative effect with significant tissue hyperthermia and prompt visual loss. For classic CNV, PDT represents an established therapy option. Positive results of the treatment of occult CNV by PDT have enlarged the use of PDT to this kind of CNV. TTT represents an economic therapy modality for (mainly) occult CNV. The effect for visual outcome varies in different studies. The results are shown in a .

M3 - SCORING: Zeitschriftenaufsatz

VL - 223

SP - 802

EP - 807

JO - KLIN MONATSBL AUGENH

JF - KLIN MONATSBL AUGENH

SN - 0023-2165

IS - 10

M1 - 10

ER -